News

A Kirby Institute initiative that will develop a digital health tool to aid the equitable elimination of cervical cancer in Australia has been awarded funding through the highly competitive Australian Government’s Medical ...

The funding, awarded though the Medical Research Future Fund, will support innovative infectious disease research including the development of RNA vaccines and treatments, clinical trials, and enhanced strategies for hepatitis C and ...

Announced by the Hon. Mark Butler, Minister for Health and Ageing, on Wednesday 13 March, a project to develop a global master protocol for randomised, placebo-controlled trials has received almost $2 million in funding through ...

Announced on Wednesday 13 March 2023, $5 million from the Medical Research Future Fund has been awarded to a Kirby Institute-led consortium that will boost development of RNA vaccines and therapeutics for COVID-19 and other health ...

Announced on Wednesday 13 March, Kirby Institute research aimed to enhance testing and treatment for hepatitis C (HCV) received $2 million through Medical Research Future Fund's Clinical Trials Activity scheme. “Australia could be one ...

The major gift will support prevention research for one of Australia’s most neglected cancers. The Kirby Institute at UNSW Sydney will establish a national program to significantly reduce the burden of anal cancer in people living ...

The analysis provides crucial information on the effectiveness of updated COVID-19 boosters.  Newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19 than the original, single-strain ...

(SEATTLE, Wednesday 22 February 2023) Two newer simplified treatment options are at least as effective as current approaches, according to the results of a world-first international clinical trial into second-line HIV therapy led ...

Vaccine manufacturers should consider updating vaccine composition to include the Omicron strain, according to the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC).  The independent and multidisciplinary ...

In Australia, a child diagnosed with a parasitic disease, whether scabies caused by skin mites, or one of the various forms of intestinal worms, can expect quick access to simple, curative treatment. But in countries where infection ...

A team of scientists at the UNSW RNA Institute, Garvan Institute of Medical Research and the Kirby Institute can now move forward to the next stage of developing a variant-proof COVID-19 vaccine, thanks to vital funding from the NSW ...

Applications are now open for the David Cooper Scholarship; an opportunity for an outstanding Australian or international candidate to complete a PhD in infectious diseases at the Kirby Institute. Established in 2021 in honour of the ...

In 2021 there were 86,916 diagnoses of chlamydia, 26,577 of gonorrhoea and 5,570 of infectious syphilis in Australia There were reductions in total chlamydia and gonorrhoea diagnoses nationally – but also a drop in the numbers of ...

The Kirby Institute and St Vincent’s Hospital were pleased to host two colleagues from Papua New Guinea to undertake intensive HIV drug resistance training. Dr Janet Gare and Helen Keno in the St Vincent's HIV Reference ...

The Kirby Institute’s Professor Miles Davenport is among a team of Australian researchers who were named as finalists in the prestigious Prime Minister’s Prize for Science. The team also includes Doherty Institute’s Professor ...

New models of care and more investment are urgently needed to reach people at risk or living with hepatitis C, and engage people lost to care, otherwise Australia risks falling short of its goal to eliminate hepatitis C as a public ...

During the pandemic regular serosurveys, testing for antibodies to the virus (SARS-CoV-2) that causes COVID-19, have been used to track the proportion of people infected. Today, results from two complementary national serosurveys, one ...

Congratulations to Dr Nila Dharan, who was awarded the Kirby Institute’s Postgraduate Student Prize for 2022. Nila Dharan is a senior research fellow with the Kirby Institute’s Biostatistics and Databases Program and Therapeutic and ...